Zobrazeno 1 - 10
of 343
pro vyhledávání: '"Joseph C, Cleveland"'
Autor:
Joseph C. Cleveland, Juan Espinoza, Elizabeth A. Holzhausen, Michael I. Goran, Tanya L. Alderete
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Social determinants of health (SDoH) describe the complex network of circumstances that impact an individual before birth and across the lifespan. SDoH contextualize factors in a community that are associated with chronic disease
Externí odkaz:
https://doaj.org/article/a991735ce82248f780ca269061f25f3b
Autor:
Navin G. Vigneshwar, MD, MPH, Muhammad F. Masood, MD, Ivana Vasic, BS, Martin Krause, MD, Karsten Bartels, MD, PHD, Mark T. Lucas, MPS, Michael Bronsert, PhD, Craig H. Selzman, MD, Shaun Thompson, MD, Jessica Y. Rove, MD, Thomas B. Reece, MD, Joseph C. Cleveland, MD, Jay D. Pal, MD, PhD, David A. Fullerton, MD, Muhammad Aftab, MD
Publikováno v:
JTCVS Open, Vol 12, Iss , Pp 211-220 (2022)
Objective: The COVID-19 pandemic presents a high mortality rate amongst patients who develop severe acute respiratory distress syndrome (ARDS). The purpose of this study was to evaluate the outcomes of venovenous extracorporeal membrane oxygenation (
Externí odkaz:
https://doaj.org/article/a6f2d38a4ef74e3baa4e5cbb5891da2d
Autor:
Megan Kunkel, BS, Peter Rothstein, MD, Peter Sauer, Matthew M. Zipse, MD, Amneet Sandhu, MS, MD, Alexis Z. Tumolo, MD, Ryan T. Borne, MD, Ryan G. Aleong, MD, Joseph C. Cleveland, Jr., MD, David Fullerton, MD, Jay D. Pal, MD, PhD, Austin S. Davies, BS, Curtis Lane, BS, Duy T. Nguyen, MD, FHRS, William H. Sauer, MD, FHRS, Wendy S. Tzou, MD, FHRS
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 3, Pp 271-279 (2021)
Background: Ventricular tachycardia (VT) catheter ablation success may be limited when transcutaneous epicardial access is contraindicated. Surgical ablation (SurgAbl) is an option, but ablation guidance is limited without simultaneously acquired ele
Externí odkaz:
https://doaj.org/article/abaca59f2f9f41429993ed3930e38ed4
Publikováno v:
US Cardiology Review, Vol 15, Iss , Pp - (2021)
For nearly 60 years, there have been two surgical treatment options for individuals with severe advanced heart failure: heart transplantation or implantation of a left ventricular assist device. As these fields have advanced in parallel, improvements
Externí odkaz:
https://doaj.org/article/99e89592d6804989bc06ca59b7e19d40
Autor:
Jonas Skogestad, Ingrid Albert, Karina Hougen, Gustav B. Lothe, Marianne Lunde, Olav Søvik Eken, Ioanni Veras, Ngoc Trang Thi Huynh, Mira Børstad, Serena Marshall, Xin Shen, William E. Louch, Emma Louise Robinson, Joseph C. Cleveland, Amrut V. Ambardekar, Jessica A. Schwisow, Eric Jonas, Ana I. Calejo, Jens Preben Morth, Kjetil Taskén, Arne Olav Melleby, Per Kristian Lunde, Ivar Sjaastad, Cathrine Rein Carlson, Jan Magnus Aronsen
Publikováno v:
Circulation. 147:1221-1236
Background: Increasing SERCA2 (sarco[endo]-plasmic reticulum Ca 2+ ATPase 2) activity is suggested to be beneficial in chronic heart failure, but no selective SERCA2-activating drugs are available. PDE3A (phosphodiesterase 3A) is proposed to be prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e63a68ac09949d6f49d8b7e1ad749c11
https://doi.org/10.1161/circulationaha.121.054168
https://doi.org/10.1161/circulationaha.121.054168
Autor:
Xianzhong Meng, Joseph C. Cleveland, Christian V. Ghincea, Gavriel F. Roda, Linling Cheng, Michael J. Weyant, David A. Fullerton, T. Brett Reece, Yuki Ikeno, Muhammad Aftab
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 165:e90-e99
OBJECTIVES The mitochondrial adenosine triphosphate-sensitive potassium channel is central to pharmacologically induced tolerance to spinal cord injury. We hypothesized that both direct and nitric oxide-dependent indirect activation of the adenosine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c90e7ffbb0c70c7a7d324c4ee30b573e
https://doi.org/10.1016/j.jtcvs.2021.08.085
https://doi.org/10.1016/j.jtcvs.2021.08.085
Autor:
Mandeep R. Mehra, Aditi Nayak, Alanna A. Morris, David E. Lanfear, Hassan Nemeh, Sapna Desai, Aditya Bansal, Cesar Guerrero-Miranda, Shelley Hall, Joseph C. Cleveland, Daniel J. Goldstein, Nir Uriel, Leway Chen, Stephen Bailey, Anelechi Anyanwu, Gerald Heatley, Joyce Chuang, Jerry D. Estep
Publikováno v:
JACC: Heart Failure. 10:948-959
BACKGROUND: Clinical trials inform on average efficacy, but individualized risk assessments for outcome prediction are important in guiding treatment implementation. OBJECTIVES: The authors developed and validated a patient-specific risk score to pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b91392eca773d14e0af7150108a2125
https://doi.org/10.1016/j.jchf.2022.08.002
https://doi.org/10.1016/j.jchf.2022.08.002
Autor:
Laura J. Davidson, Joseph C. Cleveland, Frederick G. Welt, Saif Anwaruddin, Robert O. Bonow, Michael S. Firstenberg, Mario F. Gaudino, Bernard J. Gersh, Kendra J. Grubb, Ajay J. Kirtane, Jacqueline E. Tamis-Holland, Alexander G. Truesdell, Stephan Windecker, Roza A. Taha, S. Chris Malaisrie
Publikováno v:
Journal of the American College of Cardiology. 80:2119-2134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8df17d0a4a53da510bc532843be4c523
https://doi.org/10.1016/j.jacc.2022.09.034
https://doi.org/10.1016/j.jacc.2022.09.034
Autor:
Raymond J. Strobel, Courtney Yohe Savage, Keith A. Horvath, Francis C. Nichols, Edward B. Savage, Vig Kasirajan, Joseph C. Cleveland, John E. Mayer, Stephen J. Lahey
Publikováno v:
The Annals of Thoracic Surgery. 114:1542-1549
Reimbursement for cardiothoracic surgery continues to be threatened with enormous financial cuts ranging from 5% to 10% in recent years. In this policy perspective, we describe the history of reimbursement for cardiothoracic surgery, highlight areas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cadc3af40b16513826a62d673c7fc2ea
https://doi.org/10.1016/j.athoracsur.2022.07.044
https://doi.org/10.1016/j.athoracsur.2022.07.044
Autor:
Alejandro Suarez-Pierre, John Iguidbashian, Christina Stuart, Robert W. King, Jake Cotton, Adam M. Carroll, Joseph C. Cleveland, David A. Fullerton, Jay D. Pal
Publikováno v:
The Annals of Thoracic Surgery. 114:676-682
the incidence of organ donation after circulatory death (DCD) is increasing; however, heart use has lagged behind other solid organs. Ex vivo perfusion devices are under United States Food and Drug Administration review for use in DCD heart recovery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f67a7fe09c2a1f173159938c0458785b
https://doi.org/10.1016/j.athoracsur.2022.01.042
https://doi.org/10.1016/j.athoracsur.2022.01.042